INTRODUCTION
The neural tube is the embryonic precursor of the brain and spinal cord, and is formed by the rolling up of a flat layer of ectodermal cells (the neural plate) to create a tube. In the mammalian embryo, initiation of neural tube closure occurs at three sites along the body axis (1) . The first site of de novo closure (so-called Closure 1) occurs in the future cervical region, while the second and third sites of de novo closure (Closures 2 and 3) occur at about the forebrain-midbrain boundary, and at the most rostral extent of the forebrain, respectively (1) . Closure between these three sites is responsible for the formation of the cranial neural tube, while continuation of closure caudally from the site of Closure 1 is necessary for the formation of the spinal cord.
Disruption of neural tube closure leads to a group of disorders termed neural tube defects (NTDs), which are one of the commonest causes of congenital malformation. NTDs affect around 1 in 1000 pregnancies and are either severely disabling or lethal (2) . Neural tube defects are classified according to the region of the body axis that is affected (3) . Anencephaly is the consequence of a failure to complete neural tube closure in the brain, whereas spina bifida results from disruption of neural tube closure in the lower spine. The most severe form of NTD is craniorachischisis, in which almost the entire brain and spinal cord remain open. Craniorachischisis is caused by a failure to initiate neural tube formation at Closure 1, at the start of neurulation (3) . Craniorachischisis comprises 10-20% of human NTDs (4) (5) (6) and is invariably lethal, yet the molecular mechanisms involved are poorly understood.
The estimated recurrence risk of NTD with one affected sibling is 2-5% and this increases to 16% with two affected siblings, revealing a strong genetic predisposition for NTD in humans (7) . However, direct analysis of the molecular basis of human NTDs is difficult, owing to the practical and ethical constraints of studying human embryos early in development, and the lack of suitable families available for linkage analysis. In contrast, the mouse provides an excellent model system with which to identify the molecular mechanisms involved in neural tube closure. Indeed, there are over 60 existing mouse mutants *To whom correspondence should be addressed. Tel: þ44 1235834393, ext 361; Fax: þ44 1235834776; Email: j.murdoch@har.mrc.ac.uk that exhibit defects in neurulation resulting in, predominantly, spina bifida or anencephaly (8) . Identification of the molecular mechanisms involved in craniorachischisis currently relies solely on two mutants that exhibit a failure of Closure 1: looptail (Lp) and circletail (Crc). These mutants are essential to our understanding of the molecular mechanisms involved in the initiation of neural tube closure.
Homozygous Lp/Lp embryos and homozygous Crc/Crc mutants both exhibit failure of initiation of neural tube closure in the future cervical region of the embryo (Closure 1), at E8.5. Consequently, these mutants exhibit a neural tube that remains open from the midbrain/hindbrain boundary throughout the spine (Fig. 1A-C) (9) (10) (11) , closely modelling the human condition of craniorachischisis. We, and others, recently identified the gene mutated in loop-tail as Vangl2 (formerly known as Lpp1 or Ltap) (12, 13) . Vangl2 encodes a protein related to Drosophila van gogh/strabismus, with four transmembrane domains and a putative carboxy terminal PDZbinding motif (12, 13) . Disruption of Drosophila strabismus reveals an essential role for this gene in the establishment of planar cell polarity (PCP), also known as epithelial polarity or tissue polarity (14) (15) (16) . PCP is evident in a number of tissues in Drosophila, such as the regular arrangement of ommatidia in the eye, the formation and directionality of hairs in the wing, and the arrangement of sensory bristles in the thorax. In the strabismus mutant, this regular arrangement is lost (14) (15) (16) .
Other genes known to be involved in the establishment of PCP in these tissues include frizzled, dishevelled, prickle, flamingo, rhoA and the JNK cascade (17) (18) (19) . The involvement of frizzled and dishevelled reveals molecular overlap with the Wnt signalling pathway, for which frizzled is the receptor, and dishevelled a downstream cytoplasmic factor. However, PCP appears not to involve the other downstream components of the canonical Wnt pathway, such as armadillo (b-catenin). Rather, planar cell polarity is mediated by a non-canonical Wnt signalling pathway.
Homologues of all the Drosophila PCP pathway genes exist in vertebrates, and much recent evidence implicates the vertebrate PCP pathway in the regulation of the convergent extension cell movements that occur during gastrulation and neurulation. For instance, disruption of the Xenopus or zebrafish homologues of van gogh/strabismus results in failure of convergent extension, and subsequently to failure of neural tube closure (20) (21) (22) (23) , while mutation of the JNK genes also affects convergent extension (24) . A defect in convergent extension may underlie the failure of neural tube closure in the mouse loop-tail mutant.
The circletail mouse is the only other reported mutant that exhibits failure of Closure 1. We have shown previously that Lp and Crc map to different chromosomes (1, 15) and so are not allelic (25) (26) (27) . However, Crc and Lp exhibit a genetic interaction, such that double heterozygotes (Lp/þ, Crc/þ) also exhibit craniorachischisis (25) . This reveals that Crc and Lp act either in the same developmental pathway, or in converging pathways, that is/are essential for the initiation of neural tube closure.
Here, we report the identification of the gene mutated in Crc, using a positional cloning approach. We show that this gene, Scrb1, exhibits a dynamic pattern of expression that corresponds closely to the range of phenotypic defects observed in Crc/Crc fetuses. Scrb1 encodes a putative cytoplasmic protein with four PDZ domains, leading us to speculate that the Scrb1 protein may directly interact with Vangl2, which carries a PDZ binding domain. In support of this hypothesis, we show that Scrb1 and Vangl2 exhibit overlapping expression domains in the mid-gestation embryo. Scrb1 is homologous to the Drosophila protein scribble, which has not been implicated in planar cell polarity but is involved in apical-basal polarity.
RESULTS

Scrb1 is mutated in the circletail mouse mutant
We previously mapped the Crc mutation to an 8.8 cM interval on mouse Chromosome 15, between D15Mit93 and D15Mit68 (25) . Examination of the publicly available mouse genomic sequence information (see www.ensembl.org/Mus_musculus/) identified over 100 transcripts in the 9 Mb interval between D15Mit144 (the next most proximal marker to D15Mit93) and D15Mit68. Several of the genes within the critical region appeared to be good candidates for circletail. However, one transcript, Q922S3, appeared to be a particularly striking candidate, since it encodes four PDZ domains and is, therefore, a possible interacting partner for the PDZ-binding domain protein encoded by Vangl2, the gene mutated in loop-tail (12, 13) .
Q922S3 proved to be identical to mouse scribble (GenBank accession number, AF441233; renamed Scrb1) and sequence analysis of the coding region revealed a single base insertion in the Crc mutant (3182-3183insC, codon 947), compared with wild-type DNA ( Fig. 1E and F) . The insertion is unique to the Crc mutant, and is absent from 16 other mouse strains, including the parental strains on which Crc arose, BALB/C, C57BL/6 and NMRI (11) , and the unrelated strains, CBA/Ca, 129/Ola, 129/Sv, A/WySnJ, AKR, BXSB, C57BLKS/J, DBA/2, MRL, NOD, NZB, SJL/J and Mus spretus. The insertion causes a frame shift resulting in a premature termination codon and truncation of the protein to 971 amino acids ( Fig. 1G and Fig. 2 ).
Genomic organization and alternative splicing of mouse Scrb1, which encodes a member of the LAP protein family
Comparison of genomic and cDNA sequences reveals that mouse Scrb1 contains 38 exons, ranging in size from 38 to 502 bp, and spans a genomic interval of 22.6 kb ( Fig. 1H and Table 1 ). EST database searches and reverse transcriptase (RT)-PCR reveal several alternative transcripts, with inclusion or exclusion of exons 16, 29 or 36 ( Fig. 1I-K) . The full length transcript of mouse Scrb1 is 5547 bp and encodes a putative protein of 1665 amino acids, which exhibits 88% identity with human SCRB1, 44% identity with Drosophila Scribble (Fig. 2 ) and 36% identity with C.elegans protein LET-413 (AJ276590, not shown). Scrb1 is a LAP protein, with 16 leucine rich repeats (LRRs) and four predicted PDZ domains (Fig. 1G) , two of which are lost from the truncated Crc protein (Fig. 1G ). In the alternative transcripts, exclusion of exons 16, 29 or 36 is predicted to shorten the protein by 21, 28 or 25 amino acids, respectively, although all putative peptides retain the LRRs and PDZ domains (Fig. 2) . Alternative splicing of human SCRB1 has not been reported and is not evident from EST database searches although, interestingly, the human transcript contains the region of mouse exon 16 but lacks exons 29 and 36, corresponding to the most abundant variant observed in mouse (Figs. 1I-K and 2). Drosophila scribble also demonstrates alternative splicing (28) , but differs in genomic organization and yields transcripts that are distinct from those in mouse (28) .
Scrb1 is expressed in the neuroepithelium and several additional tissues showing abnormalities in Crc mutants
In situ hybridization experiments performed with sense probes show no staining ( Fig. 3A and H, cf. B, C and I-T), whereas antisense probes reveal robust staining in a variety of tissues during embryonic and fetal development ( Fig. 3B -G, I-S). Scrb1 is expressed from at least embryonic day (E) 7.5 (not shown) and, at the time of initiation of neural tube closure, the most intense expression is detected in the neuroepithelium ( Fig. 3B-G ). This suggests that the defect in neurulation may be intrinsic to the neural plate. Less intense expression is also detected, at this stage, in the cranial mesenchyme and branchial arches ( Fig. 3D and E) and low intensity expression is seen in the somitic mesoderm ( Fig. 3F ) and, more caudally, in the lateral mesoderm (Fig. 3G ). The expression of Scrb1 appears to correlate closely with the mutant phenotype in Crc. For instance, expression in the developing somites correlates with the observation of somite disorganization in Crc/Crc embryos (Fig. 1D) . Scrb1 is also observed in the developing heart (Fig. 3I ), in correlation with the severe cardiac defects seen in Crc mutants (D.J. Henderson et al., manuscript in preparation), and in the hepatic primordium (Fig. 3J ), which appears overgrown in Crc/Crc fetuses ( Fig. 1A and data not shown). In addition, expression in the lateral mesoderm of the future body wall ( Fig. 3G and J and data not shown), may contribute to the failure of abdominal closure in Crc/Crc fetuses (Fig. 1A) .
During later developmental stages, Scrb1 is expressed in the eyelid epithelium, particularly at the region of eyelid fusion, and in the retina ( Fig. 3K and L). These expression domains correlate with the failure of Crc/Crc fetuses to form closed eyelids ( Fig. 4A and B) and with the partially penetrant defects observed in the retina (11) . Scrb1 is also expressed in the submandibular glands ( Fig. 3O ), which exhibit reduced branching in Crc mutants ( Fig. 4C and D) . The whisker and hair follicles also express Scrb1 ( Fig. 3M and N) , and these structures appear small in Crc/Crc fetuses ( Fig. 4E and F) (data not shown). Expression is also evident in the sympathetic ganglia ( Fig. 3P ), which are hypoplastic in Crc/Crc ( Fig. 4G and H), and in the developing inner ear (Fig. 3R) , which is abnormal in Crc/Crc fetuses (data not shown).
Scrb1 expression is evident in a number of other fetal tissues, including the thymus, testis, kidney, the epithelial lining of the oesophagus and stomach, the trigeminal and dorsal root ganglia, and the lung epithelia (Fig. 3P , Q, S and T), although no gross abnormalities have so far been detected in these tissues in Crc/Crc mutants. Thus, Scrb1 expression is detected in all of the tissues in which a morphological phenotype has been detected, although not all sites of Scrb1 expression exhibit a mutant phenotype, perhaps suggesting redundancy with other co-expressed genes.
Scrb1 expression domains overlap with Vangl2, a putative interacting partner
We have shown previously that the circletail mutant exhibits a genetic interaction with the loop-tail mutant, such that double heterozygotes (Crc/þ, Lp/þ) exhibit severe neural tube defects, very similar to the phenotype of individual Crc/Crc or Lp/Lp homozygotes (25) . This genetic interaction suggests a molecular interaction between Scrb1 and Vangl2, the proteins mutated in Crc and Lp. Comparison of Scrb1 and Vangl2 expression patterns reveals that many embryonic and fetal tissues co-express both genes, including the neuroepithelium, ventricular myocardium, eyelids, lung epithelium, whisker follicles and the epithelial lining of the stomach (Fig. 3I, L , N, Q and T-W) (12, and data not shown). This co-expression further supports the hypothesis that the proteins may directly interact. Furthermore, histological analysis of Crc/Crc embryos just at the stage of initiation of neural tube closure reveals an Circletail mutants exhibit no generalised defect in neuroepithelial apical-basal polarity Drosophila scribble is involved in regulating apical-basal polarity (30) . To test for a generalized loss of apical-basal polarity in circletail mutants, we stained sections with fluorescently conjugated phalloidin, which binds to F-actin. During neurulation, actin microfilaments exhibit a marked apical localization in the neuroepithelium, particularly in more cranial regions of the body axis (31) . Phalloidin staining of circletail mutant embryos both immediately before the onset of neural tube closure, at the five somite stage, and several hours after the time of initiation of neural tube closure, at the 16 somite stage, reveals no obvious defect in actin localization in the mutant embryos (Fig. 5M , N, Q and R), compared with heterozygous or wild type littermates (Fig. 5K , L, O and P).
This demonstrates that there is no general disruption in apicalbasal polarity in the Crc/Crc neuroepithelium, although we have not excluded the possibility of disruption of specific apically restricted proteins. 
DISCUSSION
We have identified a frameshift mutation in the Scrb1 gene as the cause of the craniorachischisis phenotype seen in the circletail mouse mutant. Scrb1 is initially expressed most intensely in the neuroepithelium, suggesting a defect intrinsic to the neural plate. In addition, we have shown that Scrb1 expression is associated with other regions of phenotypic abnormalities in the Crc mutants, including the heart, inner ear, whisker and hair follicles, eyelids, submandibular glands and the sympathetic ganglia. Indeed, all of the tissues that demonstrate a mutant phenotype in circletail also exhibit expression of Scrb1. Additionally, Scrb1 is expressed in a diverse array of other embryonic and fetal tissues including epithelial tissues of neuroectodermal (for example, the cochlea), endodermal (lining of the gut and stomach) and ectodermal (eyelid epithelium) origin, as well as non-epithelial tissues, such as the cranial mesenchyme.
Scrb1 may be involved in the cell movements of convergent extension
The severe neural tube defect exhibited by the circletail mutant is seen in only one other mouse mutant, loop-tail.
Although not yet specifically demonstrated, it is likely that the neurulation defect exhibited by loop-tail is caused by a disruption in the cell movements of convergent extension (13) , in which cells move towards the midline, enabling anterior-posterior elongation and medio-lateral narrowing of the embryo (32, 33) . Indeed, Lp mutants exhibit a shortened body axis and widened midline, in keeping with such a cellular defect (29, 34) . Moreover, mis-expression of the homologous genes in Xenopus and zebrafish has been clearly demonstrated to cause defects in convergent extension (19) (20) (21) (22) 24, 35) . The circletail mutant exhibits several morphological features that are similar to loop-tail, suggesting that a defect in convergent extension may underlie the neural tube defect in this mutant. Indeed, Crc/Crc embryos are shorter than their wildtype littermates (11) and we show here that they also exhibit a widened, flattened midline, in keeping with a defect in convergent extension. Moreover, intercrosses have shown that compound heterozygous embryos (Lp/þ, Crc/þ) also exhibit the severe neural tube defect (25) , indicating that the two mutations interact, presumably through effects on the same tissue.
Mammalian Scrb1 is related to Drosophila scribble, a protein involved in apical-basal polarity and tight junction formation Scrb1 encodes a member of the LAP (leucine-rich repeat and PDZ domain) protein family, most closely related to Drosophila scribble and C.elegans protein LET-413, which perform essential roles in the establishment of cellular apicalbasal polarity (30, 36) . Drosophila scribble localizes to epithelial septate junctions, while LET-413 is localized basolaterally, and disruption of either protein results in abnormal adherens junction formation and failure to restrict the localization of specific junctional and apical membrane proteins (30, 36) . This results in defects in the organization and differentiation of epithelia, with aberrant cell shapes and loss of the monolayer organization of epithelia in the embryo, larval imaginal discs and adult follicles (30, 37) . These defects become more severe as development proceeds (30) , and the abnormal epithelia also show tumour-like overgrowth (37) . Mutations in scribble were also independently identified in a screen for genes that control the immune response in Drosophila (38) . The structure of the fat body, the organ responsible for the principle humoral response to infection, is abnormal in scribble mutants, with the cells exhibiting a more rounded morphology indicative of abnormal junctional structures (38) .
Although the cellular role of mammalian Scrb1 remains to be determined, the similarity to Drosophila scribble suggests that this protein may also be involved in apical-basal polarity. Indeed, human scribble partially colocalizes with tight junctions (39) , supporting the hypothesis of functional conservation. Furthermore, increased degradation of scribble in human cells, through the ubiquitin-mediated pathway stimulated by the high-risk human papillomavirus E6 proteins, correlates with a disruption in the integrity of tight junctions (39) .
Scrb1 is initially expressed most intensely in the neuroepithelium, and the apical-basal polarity of this tissue is known to be tightly regulated during neurulation (40, 41) . Using phalloidin staining, we have demonstrated that there is no generalized loss of apical-basal polarity in the neuroepithelium of circletail mutant embryos. However, it is plausible that disruption of Scrb1 may lead to loss of the apically restricted localization of a specific subset of apical proteins, analogous to the defect observed in Drosophila scribble mutants. Such a specific defect may only become apparent once the targets of mammalian Scrb1 are identified.
The defects observed in other mutant tissues, such as the eyelid, whisker follicles and salivary glands, may also be caused by a disruption in the subcellular distribution of specific apical membrane targets of Scrb1. Alternatively, some of the observed defects may perhaps be caused by alterations in cell proliferation, since Drosophila scribble is involved in regulating proliferation (37) . It is not yet clear if the mutation of Scrb1 in circletail results in a null phenotype. While truncation of Scrb1 could destabilize the protein and lead to complete loss of function, it is also possible that the shortened Scrb1 peptide is stable, as seen in Drosophila (28) and instead could exhibit dominant-negative activity.
Genetic interaction between Lp and Crc: possible links of Scrb1 to planar cell polarity
The genetic interaction between circletail and loop-tail reveals a functional link between Scrb1 and Vangl2, since compound heterozygous mutants exhibit the same severe neural tube defect that is seen in either homozygous mutant (25) . Vangl2 is likely to participate in the vertebrate planar cell polarity pathway (14) (15) (16) 18, 19, 21, 22, 42) . Although not previously implicated in this pathway, it is possible that Scrb1 may also have some direct function in planar cell polarity, and possible molecular interactions with PCP signalling are discussed below. Alternatively, Scrb1 may affect PCP through an effect on apical-basal polarity. Indeed, correct apical-basal polarity is thought to be essential for the establishment of planar cell polarity, and these processes are closely integrated in the regulation of asymmetric cell division in Drosophila (43) . A third possibility is that mammalian Scrb1 is not required for either apical-basal or planar cell polarity, but that it functions in a distinct pathway which converges with the PCP pathway to regulate cell movements during early neurulation. Recent evidence suggests that other molecular pathways are important in regulating convergent extension cell movements, including a non-canonical FGF signalling pathway involving the marginal coil protein (44) . Intriguingly, Vangl2 may potentially interact in this pathway, since both marginal coil and Vangl2 contain coiled coil domains (12, 44) , providing the potential for direct protein interaction. Clearly, much further work is required to decipher the precise functional role of mammalian Scrb1.
Putative molecular interactions between Scrb1 and Vangl2
Although the molecular basis of the genetic interaction between Crc and Lp is unknown, a number of possibilities exist. We have excluded one hypothesis, that Crc and Lp may act in a regulatory cascade, since both Vangl2 and Scrb1 exhibit apparently normal expression in Crc/Crc and Lp/Lp mutants, respectively. Another possibility is that Scrb1 may function to control the subcellular localization of the Vangl2 protein.
Alternatively, Scrb1 and Vangl2 may form part of a protein complex, perhaps through direct interaction of the carboxyterminal PDZ-binding motif (PBM) of Vangl2 with the PDZ domains of Scrb1. The Xenopus Vangl2 homologue has been shown to bind to the PDZ domains of dishevelled although, surprisingly, the PBM of Vangl2 was not required for this interaction (20) . The PBM of Vangl2 appears to be essential in regulating cell polarity and driving convergent extension (20, 23) , suggesting that interaction of the PBM of Vangl2 with a PDZ protein other than dishevelled may be functionally important. Another hypothesis is that Scrb1 may act downstream of Vangl2 in the PCP pathway. The leucine-rich repeats of Scrb1 are similar to those found in other proteins that are known to interact with proteins of the small GTPase family (45, 46) . This raises the possibility that there may be an interaction between the Scrb1 LRRs and RhoA, a small GTPase that acts downstream in the PCP pathway (17) . Distinguishing between these possibilities requires the development of mouse-reactive anti-Vangl2 and anti-Scrb1 antibodies, and these will be the subject of future work. Moreover, the presence of four PDZ domains and 16 LRRs provides the potential for Scrb1 to exhibit multiple protein-protein interactions, with the ability to form a multiprotein complex that could be essential in linking apical-basal polarity or other signalling pathways with planar cell polarity in mammalian development.
Relevance to human disease
Despite numerous studies, the identity of the genes involved in human NTD has remained elusive (47) . Whilst the mRNA and predicted protein sequences of human SCRB1 are available, this gene has not been formally mapped and is not yet annotated in the publicly available human genome sequence databases, presumably as it lies within a region that is incompletely sequenced. However, numerous genes that closely flank Scrb1 on mouse Chromosome 15 have homologues on human Chromosome 8q24, including Ly6h and Grbp (Rhophilin1) proximally, and Plectin1, Hsf1 and Dgat1, distally. Thus, it seems very likely that human SCRB1 will also localize to this region. In support of this prediction, BLAST homology searches of the high throughput genomic sequence database with the human SCRB1 cDNA sequence identifies perfect matches in two genomic clones which have been used for lowpass sequence sampling, BACs RP11-299N14 and RP11-429J17, and a fragment from one end of clone RP11-299N14 has been localized to 8q24, in the human genomic sequence database (http://genome.cse.ucsc.edu/).
Although, to our knowledge, chromosome 8q24 has not previously been associated with human NTDs, Scrb1 represents an important new candidate for this severe congenital defect. The complex aetiology and low penetrance of NTD in humans is suggestive of a polygenic and multifactorial mode of inheritance. The severe neural tube defects demonstrated by Lp/þ, Crc/þ double heterozygotes show that mutations in two different genes can act in synergy to generate a severe phenotype. In humans, there are now numerous examples where birth defects result from double heterozygous mutations that act synergistically, including holoprosencephaly (SHH and TGIF ) (48), retinitis pigmentosa (ROM1 and RDS) (49) and Bardet-Bidel syndrome (BBS2 and BBS6 ) (50) . Despite a general lack of success at identifying causative mutations in human orthologues of mouse NTD genes, an approach that looks at multiple interacting genes, perhaps in specific biochemical pathways, may be more fruitful. The identification of Scrb1 and its interaction with Vangl2 suggests an important new candidate for NTDs in human patients.
MATERIALS AND METHODS
Mouse strains BALB/c, CBA/Ca, C57BL/6J, 129/Ola and 129/Sv were obtained from Harlan Olac (Bicester, UK); NMRI was obtained from NIH; and A/WySnJ, AKR, BXSB, C57BLKS/J, DBA/2, MRL, Mus spretus, NOD, NZB and SJL/J were obtained from the Jackson Laboratories (Bar Harbor, ME, USA). Mice carrying the Lp mutation were bred and genotyped as described previously (12, 51) . Mice carrying the Crc mutation were maintained as described previously (25) , and embryos were genotyped at D15Mit144 and D15Mit68. Embryos were harvested and processed for histology or in situ hybridization as described elsewhere (52) . Sense and antisense probes for Scrb1 were generated by transcription of a 770 bp fragment, corresponding to cDNA region 541-1310 bp, cloned into the pGEM-T (Promega) vector. The antisense probe detects all possible splice variants, and sense probes gave no staining above background.
RNA extraction and reverse transcription was performed as described (12) . Analysis of alternative splicing of exons 16, 29 and 36 was performed by RT-PCR using primers designed in flanking exons, and band identities were confirmed by sequencing.
Comparative sequence analysis of coding exons in Crc/Crc and wild-type mice was performed by direct sequencing of PCR-amplified products generated with specific primers designed within exons (for cDNA analysis) or flanking exons (for genomic DNA analysis). Sequencing reactions were analysed with a MegaBACE1000 automated sequencer (Amersham). BLAST searches were performed using the NCBI web server (http://www.ncbi.nlm.nih.gov/blast), and protein structure was analysed using the PIX package (available at the HGMP Resource Centre, Hinxton, UK).
Histological analysis was performed on embryos or fetuses embedded in paraffin wax, using standard protocols. Sections were stained with haematoxylin and eosin. Phalloidin staining was performed on sections of frozen tissue, using FITCphalloidin (Sigma) as described previously (31) .
